American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$706M |
| 2 |
Kenvue
KVUE
|
+$193M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 4 |
Entegris
ENTG
|
+$160M |
| 5 |
Merck
MRK
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$301M |
| 2 |
Visa
V
|
+$269M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$217M |
| 4 |
Allstate
ALL
|
+$172M |
| 5 |
Air Products & Chemicals
APD
|
+$163M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.13% |
| 2 | Financials | 13.26% |
| 3 | Healthcare | 12.32% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Industrials | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Clear Channel Outdoor Holdings
CCO
$1.22B
| $76.1K | ﹤0.01% |
+46,103
| New | +$78.8K |
|
2802
BioCryst Pharmaceuticals
BCRX
$2.58B
| $75.7K | ﹤0.01% |
14,899
| – | – |
|
2803
Upland Software
UPLD
$16.8M
| $75.2K | ﹤0.01% |
2,434
+212
| +10% | +$7.68K |
|
2804
Lantronix
LTRX
$279M
| $73.4K | ﹤0.01% |
+20,626
| New | +$101K |
|
|
SYRS
2805
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $72.9K | ﹤0.01% |
+13,624
| New | +$94.2K |
|
2806
Standard BioTools
LAB
$308M
| $71.5K | ﹤0.01% |
+26,383
| New | +$63.7K |
|
2807
Sabre
SABR
$839M
| $70.3K | ﹤0.01% |
29,067
+90
| +0.3% | +$302 |
|
2808
Quantum-Si Incorporated
QSI
$197M
| $63K | ﹤0.01% |
+31,982
| New | +$55.9K |
|
|
VINC
2809
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $59.7K | ﹤0.01% |
+589
| New | +$37.2K |
|
2810
BlackSky Technology
BKSY
$1.28B
| $58.8K | ﹤0.01% |
5,408
-64
| -1% | -$703 |
|
|
OPTU
2811
Optimum Communications Inc
OPTU
$230M
| $57.7K | ﹤0.01% |
22,124
+36
| +0.2% | +$91 |
|
2812
Oramed Pharmaceuticals
ORMP
$182M
| $57.2K | ﹤0.01% |
19,591
+301
| +2% | +$842 |
|
|
VTNR
2813
DELISTED
Vertex Energy, Inc
VTNR
| $56K | ﹤0.01% |
40,023
+2,174
| +6% | +$3.47K |
|
2814
Aldeyra Therapeutics
ALDX
$92.3M
| $55.1K | ﹤0.01% |
16,860
+4,107
| +32% | +$13.5K |
|
|
MAGN
2815
Magnera Corp
MAGN
$438M
| $55K | ﹤0.01% |
+2,116
| New | +$50.2K |
|
2816
LivePerson
LPSN
$35.4M
| $54.2K | ﹤0.01% |
3,622
+460
| +15% | +$15.8K |
|
2817
Crexendo
CXDO
$219M
| $52.7K | ﹤0.01% |
+10,958
| New | +$60.8K |
|
2818
Sensus Healthcare
SRTS
$53.5M
| $52.7K | ﹤0.01% |
13,867
-1,708
| -11% | -$6.19K |
|
|
TUYA
2819
Tuya Inc
TUYA
$1.1B
| $51.1K | ﹤0.01% |
29,178
| – | – |
|
2820
SGHC Ltd
SGHC
$6.62B
| $48.4K | ﹤0.01% |
14,019
-27,142
| -66% | -$86.9K |
|
2821
GSI Technology
GSIT
$261M
| $47.4K | ﹤0.01% |
+13,937
| New | +$40.3K |
|
2822
OppFi
OPFI
$612M
| $47.1K | ﹤0.01% |
+18,854
| New | +$64.1K |
|
|
AMTD
2823
AMTD IDEA Group
AMTD
$70.2M
| $46.8K | ﹤0.01% |
26,417
| – | – |
|
2824
Noodles & Co
NDLS
$101M
| $45.4K | ﹤0.01% |
2,973
-3,006
| -50% | -$58.7K |
|
|
GAU
2825
Galiano Gold
GAU
$549M
| $44K | ﹤0.01% |
31,701
-1,265
| -4% | -$1.29K |
|
Similar funds
American Century Companies's Q1 2024 Portfolio in Review
As of Q1 2024, American Century Companies held 2,999 positions worth $159B, up 9.4% from $145B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
American Century Companies's Q1 2024 filing shows 122 new, 1,903 increased, 717 reduced and 75 closed positions. Its largest new stake was Bombardier Recreational Products: 736,453 shares worth $49.4M. The largest sale was Nike, an estimated $301M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q1 2024 buy was Bombardier Recreational Products: 736,453 shares worth $49.4M.
- American Century Companies added most to Meta Platforms (Facebook) in Q1 2024, an estimated $706M increase.
- American Century Companies's biggest Q1 2024 reduction was Nike, cutting an estimated $301M.
- American Century Companies fully exited Mobileye in Q1 2024, selling an estimated $74.8M.
- American Century Companies's ten largest holdings make up 24% of its $159B portfolio in Q1 2024.
- American Century Companies opened 122 new positions and closed 75 in Q1 2024.
- American Century Companies's portfolio value rose 9.4% quarter-over-quarter to $159B.
Based on American Century Companies's 13F filing for Q1 2024, filed 14 May 2024.